BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 543212)

  • 21. Percutaneous infestation of calves and lambs with Oesophagostomum spp.
    Gerber HM
    J S Afr Vet Assoc; 1975 Sep; 46(3):273-5. PubMed ID: 1219108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of D2-E2 centers of interdomain binding of fibrin monomer during fibrinogen co-polymerization with an NH2-terminal disulfide knot of fibrin].
    Pozdniakova TM; Rybachuk VN; Ugarova TP
    Biokhimiia; 1987 Apr; 52(4):592-8. PubMed ID: 3593791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
    Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ
    Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
    Siatkovskiĭ VA; Azarova LA; Vasilenko PL
    Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Babesia bovis (argentina): analysis of fibrinogen-like proteins during infection.
    Goodger BV; Wright IG
    Z Parasitenkd; 1979 Dec; 60(3):211-20. PubMed ID: 543211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does coagulation have a causative role in eclampsia?
    Pritchard JA; Cunningham FG; Mason RA
    Perspect Nephrol Hypertens; 1976; 5():95-102. PubMed ID: 1005057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of worm burden and faecal egg count for measuring the efficacy of vaccination against Oesophagostomum radiatum.
    East IJ; Bourne AS
    Int J Parasitol; 1988 Sep; 18(6):863-4. PubMed ID: 3192358
    [No Abstract]   [Full Text] [Related]  

  • 28. Babesia bovis (argentina): observations of coagulation parameters, fibrinogen catabolism and fibrinolysis in intact and splenectomized cattle.
    Goodger BV; Wright IG
    Z Parasitenkd; 1977 Dec; 54(1):9-27. PubMed ID: 602370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
    Bini A; Fenoglio JJ; Mesa-Tejada R; Kudryk B; Kaplan KL
    Arteriosclerosis; 1989; 9(1):109-21. PubMed ID: 2643421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
    Francis CW; Connaghan DG; Scott WL; Marder VJ
    Circulation; 1987 Jun; 75(6):1170-7. PubMed ID: 3568326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivatives of fibrinogen and fibrin during defibrase therapy. Separation of high and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration.
    Asbeck F; Lechler E; Martin M; van de Loo J
    Haemostasis; 1974; 3(5-6):340-7. PubMed ID: 4468232
    [No Abstract]   [Full Text] [Related]  

  • 32. Oesophagostomum radiatum: the effect of different adjuvants on vaccination with a partially purified protective antigen.
    East IJ; Fitzgerald CJ; Berrie DA
    Vet Parasitol; 1993 Sep; 49(2-4):191-200. PubMed ID: 8249243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of fibrin(ogen) fragments in gingival crevicular fluid.
    Talonpoika J
    Scand J Dent Res; 1991 Feb; 99(1):40-3. PubMed ID: 2047751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies of coagulation-fibrinolysis system and cold insoluble globulin in cases of caesarean section].
    Mutoh S; Teh A; Shimoji Y; Nishi N; Saitoh M; Maki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2049-58. PubMed ID: 3878385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT; Francis CW
    Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
    Belousov IuB; Panchenko EP; Pivovarov VA; Nemiro VK
    Kardiologiia; 1979 Aug; 19(8):87-91. PubMed ID: 491364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
    Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
    Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI; Zubairov DM
    Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraperitoneal coagulation in chronic liver disease ascites.
    Hoefs J; Barnes T; Halle P
    Dig Dis Sci; 1981 Jun; 26(6):518-22. PubMed ID: 7238271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.